NBI-98854 50 mg capsule once daily
NBI-98854-1302
Phase 1 small_molecule completed
Quick answer
NBI-98854 50 mg capsule once daily for Effect of Ketoconazole on the PK of NBI-98854 in Healthy Subjects is a Phase 1 program (small_molecule) at NEUROCRINE BIOSCIENCES INC with 1 ClinicalTrials.gov record(s).
Program details
- Company
- NEUROCRINE BIOSCIENCES INC
- Indication
- Effect of Ketoconazole on the PK of NBI-98854 in Healthy Subjects
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed